Table 2.

Serum parameters in control group of rats and treated rats.

	In vivo treatment group
	CON	MOD	MET	EMP
Glu[mmol/L]	5.30 ± 1.40	18.90 ± 5.24****	10.11 ± 3.15##	9.64 ± 2.89##
HbA1c [%]	6.01 ± 0.65	7.31 ± 0.60**	6.49 ± 0.33#	7.13 ± 0.58
HDL-c [mmol/L]	0.66 ± 0.25	0.61 ± 0.22	0.56 ± 0.17	0.73 ± 0.32
LDL-c [mmol/L]	0.21 ± 0.07	0.56 ± 0.49	0.12 ± 0.03#	0.14 ± 0.03#
TG[mmol/L]	0.49 ± 0.31	4.04 ± 3.88*	0.58 ± 0.44#	0.60 ± 0.28#
CHO[mmol/L]	1.05 ± 0.47	2.44 ± 1.68*	0.82 ± 0.25 #	1.04 ± 0.42#
NEFA[mmol/L]	0.73 ± 0.24	1.09 ± 0.59	0.52 ± 0.17#	0.55 ± 0.15#
TNF-α(pg/ml)	46.66 ± 4.31	64.51 ± 19.07*	45.96 ± 17.58	60.17 ± 16.59
IL-1β(pg/ml)	15.16 ± 1.39	21.94 ± 7.58*	15.79 ± 3.29#	16.38 ± 2.27
IL-6(pg/ml)	116.69 ± 17.24	161.86 ± 13.38****	121.42 ± 24.76##	148.04 ± 17.94
IL-8(pg/ml)	41.05 ± 3.99	52.80 ± 7.04**	32.99 ± 9.04##	49.05 ± 9.65

^*p < 0.05,

^**p < 0.01,

^****p < 0.0001 vs. Control; #p < 0.05, ##p < 0.01 vs.MOD. Data are presented as means ± SEM.